What is LXEO's current stock price?

As of now, LXEO is trading at $9.43, with a daily change of -4.84%.

What are the risks associated with LXEO stock?

LXEO Key risk is its Low Risk Level, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

LXEO Stock Analysis & IQ Rating | Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

$9.43

-$0.48 | -4.84%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 11.72

MKT CAP

$ 656.58M

52W Low

$ 1.45

VOL

$ 1.28M

P/E Ratio

N/A

AVG VOL

$ 1.37M

RSI

64.42

TREND

Sideways

LXEO Stock IQ

Login to see Lexeo Therapeutics Inc. (LXEO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

LXEO Target Price

Login to display

Strengths

LXEO Rewards

Upgraded on attractively valued

LXEO Rewards

Earnings are forecast to grow

LXEO Rewards

Outperform the market

Chart

$6.7 (+40.75%)

$4.85 (+94.43%)

1year

6month

3month

1month

LXEO Risk Level

LXEO has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

LXEO Analysts Opinion

LXEO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

LXEO Analysts Opinion

LXEO Analysts opinion is positive and also has improved from the past 3 months

LXEO Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

LXEO Street Opinion

LXEO Street view is extremely bullish and have positive views on the near-term outlook

LXEO Performance Sentiment

Sentiments overview associated with LXEO events and the stock performance.

83%

6%

Positive

Negative

15 out of 18
events present

1 out of 18
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$9.23

Resistance
Price

$6.47

Current Price Range

$9.60

Show methods +

LXEO Latest Analysis +

Wall Street Analysts See a 108.23% Upside in Lexeo Therapeutics Inc. (LXEO): Can the Stock Really Move This High?. The consensus price target hints at a 108.2% upside potential for Lexeo Therapeutics Inc. (LXEO). While empirical research shows that this sought-after metric is hardly effective an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Thu Oct 23, 2025

$9.00 | -2.49%

Momentum

Potential

HC Wainwright & Co. Maintains Lexeo Therapeutics (LXEO) Buy Recommendation. Fintel reports that on October 21 2025 HC Wainwright &. Co. maintained coverage of Lexeo Therapeutics (NasdaqGM:LXEO) with a Buy recommendation. Analyst Price Forecast Suggests 92.81% Upside

Tue Oct 21, 2025

$9.60 | +4.12%

Rating

Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters Option to Purchase Additional Shares in the Public Offering. ) (Lexeo) a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases today announced the closing of its previously announced underwritten public offering and concurrent private placement for total gross proceeds to Lexeo of approximately $153.8 million befo

Mon Oct 20, 2025

$9.24 | -3.76%

Activity

Lexeo Therapeutics Announces FDA Support for Accelerated Approval Pathway Positive Interim Data for Gene Therapy LX2006. Lexeo Therapeutics Inc. (NASDAQ:LXEO) is one of the best young stocks with huge upside potential. On October 7 Lexeo Therapeutics announced progress regarding its gene therapy candidate LX2006 for Friedreich ataxia/FA cardiomyopathy. The company shared positive updates from discussions with the US FDA on an Accelerated Approval pathway along with encouraging new interim clinic

Fri Oct 17, 2025

$9.58 | +9.24%

Activity

Potential

Lexeo Therapeutics prices $135M public offering and private placement.

Fri Oct 17, 2025

$9.58 | +9.24%

Activity

Lexeo Therapeutics launches stock and warrant offering.

Thu Oct 16, 2025

$8.77 | -0.68%

Activity

Guggenheim Initiates Coverage of Lexeo Therapeutics (LXEO) with Buy Recommendation. Fintel reports that on October 15 2025 Guggenheim initiated coverage of Lexeo Therapeutics (NasdaqGM:LXEO) with a Buy recommendation. Analyst Price Forecast Suggests 109.14% Upside

Wed Oct 15, 2025

$8.83 | +3.88%

Rating

FAQ About LXEO Stock Insights

What is LXEO current stock price?

What are LXEO stock strengths?

What risks are associated with LXEO stock?

When is LXEO next earnings report?

What is LXEO market cap and volume?

What is LXEO's current Stock IQ?

Should I buy LXEO stock right now?

Is LXEO a Strong Buy right now?

What does a 'Strong Buy' rating mean for LXEO?

What does a 'Strong Sell' rating mean for LXEO?

What factors influence LXEO's Stock IQ?

Explore our LXEO Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored LXEO Stock Strategies
Effective Risk Management

FIND US ON

Receive our LXEO Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

LXEO

Lexeo Therapeutics Inc.

Current Price

$9.43

-$0.48 | -4.84%

52W High

$ 11.72

MKT CAP

$ 656.58M

52W Low

$ 1.45

VOL

$ 1.28M

P/E Ratio

N/A

AVG VOL

$ 1.37M

RSI

64.42

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

LXEO Rewards

Upgraded on attractively valued

LXEO Rewards

Earnings are forecast to grow

LXEO Rewards

Outperform the market

LXEO Stock IQ

Login to unlock Lexeo Therapeutics Inc. (LXEO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$6.7 (+40.75%)

$4.85 (+94.43%)

1year

6month

3month

1month

LXEO Analysts Opinion

LXEO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

LXEO Analysts Opinion

LXEO Analysts opinion is positive and also has improved from the past 3 months

LXEO Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

LXEO Street Opinion

LXEO Street view is extremely bullish and have positive views on the near-term outlook

LXEO Risk Level

LXEO has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

LXEO Performance Sentiment

Sentiments overview associated with LXEO events and the stock performance.

83%

6%

Positive

Negative

15 out of 18
events present

1 out of 18
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$9.23

Resistance
Price

$6.47

Current Price Range

$9.60

Show methods +

LXEO Latest Analysis

Wall Street Analysts See a 108.23% Upside in Lexeo Therapeutics Inc. (LXEO): Can the Stock Really Move This High?. The consensus price target hints at a 108.2% upside potential for Lexeo Therapeutics Inc. (LXEO). While empirical research shows that this sought-after metric is hardly effective an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Thu Oct 23, 2025

$9.00 | -2.49%

Momentum

Potential

HC Wainwright & Co. Maintains Lexeo Therapeutics (LXEO) Buy Recommendation. Fintel reports that on October 21 2025 HC Wainwright &. Co. maintained coverage of Lexeo Therapeutics (NasdaqGM:LXEO) with a Buy recommendation. Analyst Price Forecast Suggests 92.81% Upside

Tue Oct 21, 2025

$9.60 | +4.12%

Rating

Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters Option to Purchase Additional Shares in the Public Offering. ) (Lexeo) a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases today announced the closing of its previously announced underwritten public offering and concurrent private placement for total gross proceeds to Lexeo of approximately $153.8 million befo

Mon Oct 20, 2025

$9.24 | -3.76%

Activity

Lexeo Therapeutics Announces FDA Support for Accelerated Approval Pathway Positive Interim Data for Gene Therapy LX2006. Lexeo Therapeutics Inc. (NASDAQ:LXEO) is one of the best young stocks with huge upside potential. On October 7 Lexeo Therapeutics announced progress regarding its gene therapy candidate LX2006 for Friedreich ataxia/FA cardiomyopathy. The company shared positive updates from discussions with the US FDA on an Accelerated Approval pathway along with encouraging new interim clinic

Fri Oct 17, 2025

$9.58 | +9.24%

Activity

Potential

Lexeo Therapeutics prices $135M public offering and private placement.

Fri Oct 17, 2025

$9.58 | +9.24%

Activity

Lexeo Therapeutics launches stock and warrant offering.

Thu Oct 16, 2025

$8.77 | -0.68%

Activity

Guggenheim Initiates Coverage of Lexeo Therapeutics (LXEO) with Buy Recommendation. Fintel reports that on October 15 2025 Guggenheim initiated coverage of Lexeo Therapeutics (NasdaqGM:LXEO) with a Buy recommendation. Analyst Price Forecast Suggests 109.14% Upside

Wed Oct 15, 2025

$8.83 | +3.88%

Rating

Discover LXEO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of LXEO. We're here to help you make informed investment decisions today.

FIND US ON

Receive our LXEO Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

LXEO Stock trends

LXEO Stock performance

LXEO Stock analysis

LXEO investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LXEO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LXEO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

LXEO Stock Analysis & IQ Rating | Lexeo Therapeutics Inc.

LXEO Stock IQ

LXEO Target Price

LXEO Risk Level

LXEO Analysts Opinion

LXEO Street Consensus

LXEO Performance Sentiment

Technical Price Levels

Explore our LXEO Stock insights

Receive our LXEO Daily Alerts

LXEO Stock IQ

LXEO Street Consensus

LXEO Risk Level

Technical Price Levels

Discover LXEO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of LXEO. We're here to help you make informed investment decisions today.

Receive our LXEO Daily Alerts

LXEO Runner Alarm